The rise of more transparent, “Cost Plus” pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs. In January 2022, entrepreneur Mark Cuban ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback